Concepedia
Publication | Open Access
ADXS31142 Immunotherapy ± Pembrolizumab Treatment for Metastatic Castration-Resistant Prostate Cancer: Open-Label Phase I/II KEYNOTE-046 Study
38
Citations
8
References
2022
Year
NCT02325557.
Page 1